Navigation Links
PhRMA Elects Four New Members to Board of Directors
Date:12/21/2010

WASHINGTON, Dec. 21, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the election of four new members to its Board of Directors.

"We are pleased to welcome four new biopharmaceutical heavyweights to join PhRMA's Board of Directors," said PhRMA President and Chief Executive Officer John J. Castellani.  "As leaders of one of the most research-intensive sectors in the U.S., they bring to the table incredible insight and a keen understanding of the challenging economic, legislative and regulatory environments the industry faces on a daily basis."  

Castellani continued, "Despite these challenges, our Board of Directors has made it a top priority to build upon core patient-centered principles that guide our advocacy efforts as we work to advance public policies that foster medical innovation and help the U.S. maintain its global leadership in medical discovery.  We look forward to working with all our Board members to this aim in the months and years ahead."  

Ian Read was recently named President and Chief Executive Officer of Pfizer Inc.  Previously, he served as Senior Vice President, Pfizer Inc., and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010.  In that role, he oversaw five global business units – Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets.  

Mr. Read began his career with Pfizer in 1978 as an operational auditor.  He held various positions, including Chief Financial Officer, Pfizer Mexico in Pfizer's Latin America operations.  In 1996, Mr. Read was appointed President of Pfizer's International Pharmaceuticals Groups, with responsibility for Latin America and Canada.  He became Executive Vice President, Europe in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition t
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
3. Seven New Biopharmaceutical Research Companies Join PhRMAs Mission to Advance Medical Innovation
4. PhRMA Honors Patient Advocates Ron and Raychel Bartek
5. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
6. PhRMA Statement on Health Care Reform
7. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
8. PhRMA Statement on Department of Homeland Security Efforts to Crack Down on Counterfeiting Crimes
9. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
10. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
11. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... Laboratory Supply Company (LABSCO), the largest privately held ... hospitals, physician office laboratories, reference labs and other non-acute ... industry veteran Rod Wolford to its board ... during an incredible time of growth and opportunity, and ...
... WITTEN, Germany, September 19, 2011 Official ... plans to start treatment in 22 hospitals ... Devices officially registered the entire current range of Sangui developed ... use this treatment on a nationwide basis. In ...
Cached Medicine Technology:Rod Wolford Joins LABSCO Board of Directors 2Mexico Authorizes use of Sangui Developed Wound Management System 2Mexico Authorizes use of Sangui Developed Wound Management System 3Mexico Authorizes use of Sangui Developed Wound Management System 4
(Date:5/17/2013)... (PRWEB) May 17, 2013 Fighting addiction ... complications, but for diabetics, treatment is more difficult and ... medical care to monitor blood sugar levels and administer ... properly, a drug rehab for diabetics needs ... and nutritional needs of the diabetic, and has experience ...
(Date:5/17/2013)... "screen time" and sleep on mood, memory and ... at the 2013 Intel International Science and Engineering ... school students. The awards are coordinated by the ... the National Institutes of Health, and Friends of ... Intel ISEF Addiction Science Awards were presented at ...
(Date:5/17/2013)... Too few obstetrics-gynecology residents in the United States receive ... issues for the rapidly growing number of older American ... ob/gyn residents and found that fewer than one in ... though seven in 10 would like to receive it. ... -- those soon to complete their training -- said ...
(Date:5/17/2013)... (SACRAMENTO, Calif.) Working with lab mice models of ... novel molecular target for the design of drugs that ... medications against MS. , The findings of the ... EMBO Molecular Medicine could have therapeutic applications for ... disorders associated with loss of white matter, which is ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 The ... news on the site for women using the vaginal ... panel shows the number of claims alleging blood clots ... was created to improve the safety of patients using ... research and legal news. Visitors can find out if ...
Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2Health News:Study identifies new approach to improving treatment for MS and other conditions 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
... Four days after an Indian pilgrim died of respiratory ... the Indo-China border, another Indian woman too succumbed// to ... that one of the holiest pilgrim sites in Asia ... Indian travellers. ,Meenakshi Devi Shriram Bhoyar, a ...
... the Intellectual Property law raised a lot of oppositions from ... mainly aim to restrict the government from buying the cheap ... tuberculosis. Officials point out to the fact that these changes ... are cheaper. The NGOs are also against an amendment as ...
... agreed to provide a grant assistance of Rs.190 million ... (IIPI) campaign// in India this year, parliament was informed ... Welfare Minister Anbumani Ramadoss told the Lok Sabha: 'The ... UNICEF to be used during the pulse polio rounds ...
... a therapy that eases iron overload, according to researchers. ... the current issue of Human Reproduction. ,Women ... which attaches to ligaments and organs in the abdomen. ... infertility and adhesions. About 10 percent of women may ...
... Uttar Pradesh government has asked medical officials in the district ... villages of Loni and Bhojpur blocks// where two suspected cases ... directives were issued by the UP Health Secretary and the ... about it, District Magistrate M K S Sundaram said today., ...
... Women in the age of 40 to 50 years are ... play a vital role in the disease because of the ... A new study has examined the role played by estradiol, ... women and how it works in the development of osteoarthritis. ...
Cached Medicine News:Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2Health News:Knee Osteoarthritis May Be Triggered By Low Levels Of Estrogen 2
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
Medicine Products: